HUE050045T2 - Fenofibrát vagy annak származékának felhasználása diabéteszes retinopátia megelõzésére - Google Patents

Fenofibrát vagy annak származékának felhasználása diabéteszes retinopátia megelõzésére

Info

Publication number
HUE050045T2
HUE050045T2 HUE16185410A HUE16185410A HUE050045T2 HU E050045 T2 HUE050045 T2 HU E050045T2 HU E16185410 A HUE16185410 A HU E16185410A HU E16185410 A HUE16185410 A HU E16185410A HU E050045 T2 HUE050045 T2 HU E050045T2
Authority
HU
Hungary
Prior art keywords
fenofibrate
derivative
diabetic retinopathy
preventing diabetic
preventing
Prior art date
Application number
HUE16185410A
Other languages
English (en)
Inventor
Jean-Claude Ansquer
Anthony Keech
Original Assignee
Bgp Products Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36130110&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE050045(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bgp Products Operations Gmbh filed Critical Bgp Products Operations Gmbh
Publication of HUE050045T2 publication Critical patent/HUE050045T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE16185410A 2005-11-10 2006-11-10 Fenofibrát vagy annak származékának felhasználása diabéteszes retinopátia megelõzésére HUE050045T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05292388A EP1785133A1 (en) 2005-11-10 2005-11-10 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy

Publications (1)

Publication Number Publication Date
HUE050045T2 true HUE050045T2 (hu) 2020-11-30

Family

ID=36130110

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE06829976A HUE030936T2 (hu) 2005-11-10 2006-11-10 Fenofibrát vagy származékának felhasználása a diabeteses retinopathia kezelésében
HUE16185410A HUE050045T2 (hu) 2005-11-10 2006-11-10 Fenofibrát vagy annak származékának felhasználása diabéteszes retinopátia megelõzésére

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HUE06829976A HUE030936T2 (hu) 2005-11-10 2006-11-10 Fenofibrát vagy származékának felhasználása a diabeteses retinopathia kezelésében

Country Status (18)

Country Link
US (1) US20090170939A1 (hu)
EP (3) EP1785133A1 (hu)
JP (1) JP5171635B2 (hu)
KR (1) KR20080074877A (hu)
CN (2) CN101304742A (hu)
AU (1) AU2006313711B2 (hu)
BR (1) BRPI0618283A2 (hu)
CA (1) CA2628508C (hu)
EA (1) EA014755B1 (hu)
ES (2) ES2805227T3 (hu)
HU (2) HUE030936T2 (hu)
IL (1) IL191208A (hu)
LT (1) LT3167882T (hu)
PL (2) PL3167882T3 (hu)
PT (2) PT1954261T (hu)
SI (1) SI3167882T1 (hu)
UA (1) UA99093C2 (hu)
WO (1) WO2007054566A2 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102304103A (zh) * 2011-06-03 2012-01-04 郑州泰基鸿诺药物科技有限公司 一种非诺贝特酸盐、制备方法、药物组合物及应用
CA2928702A1 (en) * 2013-10-25 2015-04-30 Children's Medical Center Corporation Methods of treating or preventing vascular diseases of the retina

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2494112B1 (hu) 1980-11-19 1986-01-10 Laruelle Claude
FR2602423B1 (fr) 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
SI9500173B (sl) 1995-05-19 2002-02-28 Lek, Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
DE19608750A1 (de) 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Verfahren zur Herstellung von Fenofibrat-Präparaten
FR2758459B1 (fr) 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6465011B2 (en) 1999-05-29 2002-10-15 Abbott Laboratories Formulations comprising lipid-regulating agents
PL361097A1 (en) * 2000-10-12 2004-09-20 Nissan Chemical Industries, Ltd. Preventives and remedies for complications of diabetes
IL155524A0 (en) * 2000-10-26 2003-11-23 Fournier Lab Ireland Ltd Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
ATE357216T1 (de) 2001-02-22 2007-04-15 Jagotec Ag Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
JP4590159B2 (ja) * 2001-04-04 2010-12-01 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド グルコース再吸収阻害剤およびｐｐａｒモジュレーターを含んで成る併用療法
CN100348189C (zh) * 2002-12-10 2007-11-14 诺瓦提斯公司 DPP－IV抑制剂与PPAR－α化合物的组合
US7259186B2 (en) 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
EP1587535A4 (en) * 2003-01-17 2010-02-24 Merck & Co Inc N-CYCLOHEXYLAMINOCARBONYL BENZENESULFONAMIDE DERIVATIVES
EP1714648A4 (en) * 2004-02-09 2010-05-26 Aska Pharm Co Ltd COMBINATION DRUGS

Also Published As

Publication number Publication date
SI3167882T1 (sl) 2020-09-30
PT3167882T (pt) 2020-07-13
CN103417524A (zh) 2013-12-04
ES2605025T3 (es) 2017-03-10
HUE030936T2 (hu) 2017-06-28
WO2007054566A3 (en) 2007-08-23
ES2805227T3 (es) 2021-02-11
EA200801023A1 (ru) 2008-10-30
IL191208A0 (en) 2009-08-03
JP2009515856A (ja) 2009-04-16
CA2628508C (en) 2013-11-12
CN101304742A (zh) 2008-11-12
EP3167882A1 (en) 2017-05-17
KR20080074877A (ko) 2008-08-13
CA2628508A1 (en) 2007-05-18
PT1954261T (pt) 2016-11-29
EP1785133A1 (en) 2007-05-16
EP1954261B1 (en) 2016-08-24
US20090170939A1 (en) 2009-07-02
IL191208A (en) 2017-08-31
AU2006313711A9 (en) 2021-04-01
PL3167882T3 (pl) 2020-11-16
EP3167882B1 (en) 2020-04-08
BRPI0618283A2 (pt) 2012-02-28
AU2006313711A1 (en) 2007-05-18
EA014755B1 (ru) 2011-02-28
LT3167882T (lt) 2020-07-27
JP5171635B2 (ja) 2013-03-27
EP1954261A2 (en) 2008-08-13
WO2007054566A2 (en) 2007-05-18
AU2006313711B2 (en) 2012-02-23
UA99093C2 (ru) 2012-07-25
PL1954261T3 (pl) 2017-07-31

Similar Documents

Publication Publication Date Title
IL189212A0 (en) Therapeutic agent for diabetes
TWI368497B (en) Disposable diaper
EP1880700A4 (en) DISPOSABLE LAYER
IL224109A (en) Isoxazole derivatives for use as fungicides
PL2094173T3 (pl) Jednorazowa rękojeść do witrektomii
EP2105115A4 (en) DISPOSABLE LAYER
EP1920350A4 (en) TANK-BASED EXTENSIBILITY FOR USER INTERFACES
EP1990034A4 (en) DISPOSABLE LAYER
IL192369A0 (en) Therapeutic agent for diabetes
GB0715757D0 (en) Surgical implement detector
IL193159A0 (en) Pyridin-4- ylmethylamides for combating pests
EP1917944A4 (en) DISPOSABLE LAYER
EG25359A (en) Disposable diaper.
GB0621324D0 (en) Tissue processor
EP2067459A4 (en) DISPOSABLE DIAPERS
EP2077266A4 (en) 2-PYRIDINCARBOXYL ACID AMID DERIVATIVE WITH GK ACTIVATING EFFECT
IL240118A0 (en) Biological glue without thrombin and its use as a medicine
PL1693027T3 (pl) Końcówka do fakoemulsyfikacji
EP2027840A4 (en) DISPOSABLE LAYER
EP1862153A4 (en) OPHTHALMIC CANNULA
IL195355A0 (en) Substituted pyrazinone derivatives for use as a medicine
IL191208A0 (en) Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
AU2006313711A2 (en) Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
HU0600409D0 (en) Izatin and it's derivatives for use as a medicine
SI1927353T1 (sl) Zdravilo za bolezni roženice